Sangamo BioSciences | Capital De Empréstimo

Preço das Ações
0.39
Mudança Diária
-0.04 -8.84%
Mensal
8.80%
Anual
-54.41%
Q1 Previsão
0.42




Capital De Empréstimo Alterar Data
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Alterity Therapeutics Limited AUD 103.21K 73.88K 2023-06
Amgen USD 50B 2.43B 2025-12
Bayer EUR 32.71B 1B 2025-09
BioCryst Pharmaceuticals USD 194.37M 48.43M 2025-09
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Cipla INR 2.98B 454.6M 2025-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Grifols EUR 10.67B 564.4M 2025-09
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
J&J USD 39.44B 30M 2025-12
Karyopharm Therapeutics USD -0.93 0.67 2024-12
Merck USD 39.97B 6B 2025-09
Novartis USD 24.24B 174M 2025-09
Omeros USD 403.72M 27.2M 2024-06
Pfizer USD 57.41B 93M 2025-09
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Tectonic Therapeutic USD 100K 86K 2025-09
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03


Sangamo BioSciences Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.